Invitrogen™ Human SOX9 ELISA Kit

Ref.: BL-RE-106030Manufacturer ref.: EH435RB 96 tests
€734.00 excl. VAT

Human SOX9 quantitates human SOX9 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human SOX9.

Accession number
2010306G03Rik ; AV220920 ; CMD1 ; CMPD1 ; mKIAA4243 ; SOX 9 ; So x 9 ; SOX-9 ; SRA1 ; SRX x 2 ; SRXY10 ; SRY (région de détermination du sexe Y)-boîte 9 ; SRY (région de détermination du sexe Y)-boîte 9 (dysplasie campomélique, inversion sexuelle autosomique) ; SRY (région de détermination du sexe Y)-boîte 9 ; protéine de SRY (région de détermination du sexe Y)-boîte 9 ; SRY boîte 9 ; SRY-boîte 9 ; SRY-boîte 9 ; contenant le SRY-boîte 9 ; gène contenant le SRY-boîte 9 ; protéine contenant le SRY-boîte 9 ; boîte HMG liée à SRY, gène 9 ; facteur de transcription SOX-9
Dose range
0.41 to 100 pg/ml
Sensitivity of the dosage
0.41 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human SOX9 quantitates human SOX9 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human SOX9.

Human SOX9 quantitates human SOX9 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human SOX9.

SOx9 plays a role in the sexual determination and differentiation of Sertoli cells. It is involved in chondrogenesis and regulates the expression of other genes involved in chondrogenesis by acting as transcription factor for these genes. Translocation of this gene can cause campomeric dysplasia. SOx9 is involved in the formation of testicles of indifferent foetal gonads. It is a major molecular component of neurone-glie switching in spinal cord development. During normal development, SOX9 allows prostate epithelium to develop in mesenchyma, and then provides basal cell support for the development and maintenance of luminal epithelium. These SOX9 functions are subverted into prostate cancer to promote tumour growth and invasion. SOx9 can direct the formation of neural peak precursors and the development of a range of neural peak derivatives. It has transcriptional regulation in the production of melanin in cells. Northern transfer analysis shows its expression on adult testicles, adult heart and fetal brain.

Sensitivity

Sensitivity of dosage: 0.41 ng/ml.

Measurement range

Dose range: 0.41 to 100 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: SOX9.

Samples

Sample type: Plasma, Serum, Surnatant (Serum volume, 50 µl; Supernatant, 50 µl; Plasma, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17124743
Specifications
Accession number2010306G03Rik; AV220920; CMD1; CMPD1; mKIAA4243; SOX 9; So x 9; SOX-9; SRA1; SRX x 2; SRXY10; SRY (Y sex determination region)-box 9; SRY (Y sex determination region)-box 9 (campomeric dysplasia, autosomal sexual inversion); SRY (gender determination region Y
Dose range0.41 to 100 pg/ml
Sensitivity of the dosage0.41 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)P48436
Gene symbol(s)SOX9
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kits96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity96 tests
Regulatory statusUse exclusively for research
TargetSOX9
Test time1 h 20 min
Physical characteristics
Volume of sampleSerum, 50 µl; Supernatant, 50 µl; Plasma, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH435RB
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.